Clinical Trial Update: TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update of the TPM regimen (Thalidomide, Prednisone, and Methotrexate) in T-LGL leukemia and clpd-Nk; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorder of Nk Cells
• T-lgl Leukemia

Drugs mentioned

• TPM regimen

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: T-LGL Leukemia, Clpd-Nk | Phase 2, Phase 3 | Status: UNKNOWN